4.8 Article

Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays

期刊

NATURE BIOTECHNOLOGY
卷 18, 期 9, 页码 1001-1005

出版社

NATURE AMERICA INC
DOI: 10.1038/79269

关键词

-

资金

  1. NCI NIH HHS [5T34CA72320-03] Funding Source: Medline
  2. NHGRI NIH HHS [HG01806] Funding Source: Medline
  3. NATIONAL CANCER INSTITUTE [T32CA072320] Funding Source: NIH RePORTER
  4. NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001806] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Human cancers arise by a combination of discrete mutations and chromosomal alterations. Loss of heterozygosity (LOH) of chromosomal regions bearing mutated tumor suppressor genes is a key event in the evolution of epithelial and mesenchymal tumors'. Global patterns of LOH can be understood through allelotyping of tumors with polymorphic genetic markers(2), Simple sequence length polymorphisms (SSLPs, or microsatellites) are reliable genetic markers for studying LOH3, but only a modest number of SSLPs are used in LOH studies because the genotyping procedure is rather tedious. Here, we report the use of a highly parallel approach to genotype large numbers of single-nucleotide polymorphisms (SNPs) for LOH, in which samples are genotyped for nearly 1,500 loci by performing 24 polymerase chain reactions (PCR), Fooling the resulting amplification products and hybridizing the mixture to a high-density oligonucleotide array(4). We characterize the results of LOH analyses on human small-cell lung cancer (SCLC) and control DNA samples by hybridization. We show that the patterns of LOH are consistent with those obtained by analysis with both SSLPs(5) and comparative genomic hybridization (CGH), whereas amplifications rarely are detected by the SNP array. The results validate the use of SNP array hybridization for tumor studies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据